| 737138 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
In vitro Comparison of Pancreatic Enzyme Preparations Available in the Indian Market |
2021-09-01 |
10.2147/dddt.s319949 |
Shrikhande Shailesh V, Prasad VG Mohan, Domínguez-Muñoz J Enrique, Weigl Kevin E, Sarda Kushal D |
| 737137 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment |
2021-09-01 |
10.2147/dddt.s323360 |
Wang Kunpeng, Miao Xiongying, Kong Fanhua, Huang Siqi, Mo Jinggang, Jin Chong, Zheng Yanwen |
| 737136 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
The Anticancer Potential of Maslinic Acid and Its Derivatives: A Review |
2021-09-01 |
10.2147/dddt.s326328 |
Yu Lei, Xie Xiaofang, Cao Xiaoyu, Chen Junren, Chen Guanru, Chen Yan, Li Gangmin, Qin Junyuan, PENG Fu, Peng Cheng |
| 737135 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Resveratrol Pretreatment Inhibits Myocardial Apoptosis in Rats Following Coronary Microembolization via Inducing the PI3K/Akt/GSK-3β Signaling Cascade |
2021-09-01 |
10.2147/dddt.s323555 |
Li Tao, Chen Zhiqing, Zhou You, Li Haoliang, Xie Jian, Li Lang |
| 737134 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
The Jieduan-Niwan (JDNW) Formula Ameliorates Hepatocyte Apoptosis: A Study of the Inhibition of E2F1-Mediated Apoptosis Signaling Pathways in Acute-on-Chronic Liver Failure (ACLF) Using Rats |
2021-09-01 |
10.2147/dddt.s308713 |
Hou Weixin, Hao Yulin, Yang Wenlong, Tian Tian, Fang Peng, Du Yuqiong, Gao Lianyin, Gao Yanbin, Zhang Qiuyun |
| 737133 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Determination of the 90% Effective Dose of Phenylephrine Boluses to Treat Spinal Anesthesia-Induced Hypotension in Patients with Severe Preeclampsia during Cesarean Delivery: A Pilot Study |
2021-09-01 |
10.2147/dddt.s323715 |
Liu Jin-Ping, Pan Zheng-Bin, Zhu Miao, Zhu Guo-Wei, Song Da-Bing, Chen Xin-Zhong, Qian Xiao-Wei |
| 737132 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury |
2021-09-01 |
10.2147/dddt.s328837 |
Yang Tong, Chen Xiangyu, Mei Zhigang, Liu Xiaolu, Feng Zhitao, Liao Jun, Deng Yihui, Ge Jinwen |
| 737131 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date |
2021-09-01 |
10.2147/dddt.s281614 |
Yilmaz Umut, Salihoglu Ayse, Soysal Teoman |
| 737130 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Bardoxolone-Methyl Prevents Oxidative Stress-Mediated Apoptosis and Extracellular Matrix Degradation in vitro and Alleviates Osteoarthritis in vivo |
2021-09-01 |
10.2147/dddt.s314767 |
Pang Zhiying, Jiang Zengxin, Zhu Runwen, Song Chunfeng, Tang Han, Cao Lu, Guo Changan |
| 737129 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Pore-Forming Toxins During Bacterial Infection: Molecular Mechanisms and Potential Therapeutic Targets |
2021-09-01 |
10.2147/dddt.s322393 |
Hu Haijie, Liu Min, Sun Shuang |
